To meet the requirements of international standards (PIC/S) and to cater to their overseas and domestic markets, the company has built up a new factory plant. The new facilities
and operations conforming to current Good Manufacturing Practices and the latest international standards in pharmaceutical production. This envisages provisions would take into
account the current and future plans & strategies of the company to find an optimal solution without sacrificing the quality.
For this purpose, NNE Pharmaplan has appointed to carry out Conceptual Design study incorporating the latest cGMP standards and best practices for the new formulation facilities.
The new formulation plant will have two seperated buildings of manufacturing facility for:
• Non-Betalactam Group for Non-sterile Oral Therapeutical Drugs & Injectables Solution.
• Cephalosporin Group for Non-sterile Oral Therapeutical Drugs & Injectables Powder.